Paul Tudor Jones II's position in Lilly(Eli) is currently worth $39.8 Million. That's 0.36% of their equity portfolio (48th largest holding). The first Lilly(Eli) trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 32 more times and sold shares on 31 occasions. The investor's estimated purchase price is $44.8 Million, resulting in a loss of 11%.
… -Metabolic Medicine, Boehringer Ingelheim Pharmaceuticals , Inc. "Building … side effects of prescription drugs to the FDA. … 2023 Boehringer Ingelheim and...
Driven by novel drugs from Biogen (BIIB) and Eli Lilly (LLY), the Alzheimer’s disease market will hit $13.7B in 2030, according to a new industry report. Rea...
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) said the DINAMO phase III clinical trial met its primary endpoint by showing a statistically significant...